US20030044787A1
(en)
|
2000-05-16 |
2003-03-06 |
Joung J. Keith |
Methods and compositions for interaction trap assays
|
US7476500B1
(en)
|
2001-03-19 |
2009-01-13 |
President And Fellows Of Harvard College |
In vivo selection system for enzyme activity
|
AU2006282983B2
(en)
|
2005-08-26 |
2012-08-02 |
Dupont Nutrition Biosciences Aps |
Use
|
US8546553B2
(en)
|
2008-07-25 |
2013-10-01 |
University Of Georgia Research Foundation, Inc. |
Prokaryotic RNAi-like system and methods of use
|
CN102159722B
(zh)
|
2008-08-22 |
2014-09-03 |
桑格摩生物科学股份有限公司 |
用于靶向单链切割和靶向整合的方法和组合物
|
US20100076057A1
(en)
|
2008-09-23 |
2010-03-25 |
Northwestern University |
TARGET DNA INTERFERENCE WITH crRNA
|
US9404098B2
(en)
|
2008-11-06 |
2016-08-02 |
University Of Georgia Research Foundation, Inc. |
Method for cleaving a target RNA using a Cas6 polypeptide
|
WO2011091324A2
(en)
|
2010-01-22 |
2011-07-28 |
The Scripps Research Institute |
Methods of generating zinc finger nucleases having altered activity
|
GB201122458D0
(en)
|
2011-12-30 |
2012-02-08 |
Univ Wageningen |
Modified cascade ribonucleoproteins and uses thereof
|
US9637739B2
(en)
|
2012-03-20 |
2017-05-02 |
Vilnius University |
RNA-directed DNA cleavage by the Cas9-crRNA complex
|
WO2013141680A1
(en)
|
2012-03-20 |
2013-09-26 |
Vilnius University |
RNA-DIRECTED DNA CLEAVAGE BY THE Cas9-crRNA COMPLEX
|
LT2800811T
(lt)
|
2012-05-25 |
2017-09-11 |
The Regents Of The University Of California |
Būdai ir kompozicijos, skirti tikslinės dnr modifikavimui, panaudojant adresuotą rnr, ir transkripcijos moduliavimui, panaudojant adresuotą rnr
|
WO2013188638A2
(en)
|
2012-06-15 |
2013-12-19 |
The Regents Of The University Of California |
Endoribonucleases and methods of use thereof
|
EP2877213B1
(en)
|
2012-07-25 |
2020-12-02 |
The Broad Institute, Inc. |
Inducible dna binding proteins and genome perturbation tools and applications thereof
|
WO2014022702A2
(en)
|
2012-08-03 |
2014-02-06 |
The Regents Of The University Of California |
Methods and compositions for controlling gene expression by rna processing
|
KR101656237B1
(ko)
|
2012-10-23 |
2016-09-12 |
주식회사 툴젠 |
표적 DNA에 특이적인 가이드 RNA 및 Cas 단백질을 암호화하는 핵산 또는 Cas 단백질을 포함하는, 표적 DNA를 절단하기 위한 조성물 및 이의 용도
|
US20160010154A1
(en)
|
2012-11-30 |
2016-01-14 |
The Parkinson's Institute |
Screening assays for therapeutics for parkinson's disease
|
PL3138910T3
(pl)
|
2012-12-06 |
2018-01-31 |
Sigma Aldrich Co Llc |
Oparta na CRISPR modyfikacja i regulacja genomu
|
WO2014093479A1
(en)
|
2012-12-11 |
2014-06-19 |
Montana State University |
Crispr (clustered regularly interspaced short palindromic repeats) rna-guided control of gene regulation
|
KR20150105634A
(ko)
|
2012-12-12 |
2015-09-17 |
더 브로드 인스티튜트, 인코퍼레이티드 |
서열 조작을 위한 개선된 시스템, 방법 및 효소 조성물의 유전자 조작 및 최적화
|
WO2014093694A1
(en)
|
2012-12-12 |
2014-06-19 |
The Broad Institute, Inc. |
Crispr-cas nickase systems, methods and compositions for sequence manipulation in eukaryotes
|
WO2014093709A1
(en)
|
2012-12-12 |
2014-06-19 |
The Broad Institute, Inc. |
Methods, models, systems, and apparatus for identifying target sequences for cas enzymes or crispr-cas systems for target sequences and conveying results thereof
|
EP3825401A1
(en)
|
2012-12-12 |
2021-05-26 |
The Broad Institute, Inc. |
Crispr-cas component systems, methods and compositions for sequence manipulation
|
US8697359B1
(en)
|
2012-12-12 |
2014-04-15 |
The Broad Institute, Inc. |
CRISPR-Cas systems and methods for altering expression of gene products
|
IL239317B
(en)
|
2012-12-12 |
2022-07-01 |
Broad Inst Inc |
Providing, engineering and optimizing systems, methods and compositions for sequence manipulation and therapeutic applications
|
EP2940140B1
(en)
|
2012-12-12 |
2019-03-27 |
The Broad Institute, Inc. |
Engineering of systems, methods and optimized guide compositions for sequence manipulation
|
PT2784162E
(pt)
|
2012-12-12 |
2015-08-27 |
Broad Inst Inc |
Engenharia de sistemas, métodos e composições guia otimizadas para a manipulação de sequências
|
WO2014093701A1
(en)
|
2012-12-12 |
2014-06-19 |
The Broad Institute, Inc. |
Functional genomics using crispr-cas systems, compositions, methods, knock out libraries and applications thereof
|
PL2931898T3
(pl)
|
2012-12-12 |
2016-09-30 |
Le Cong |
Projektowanie i optymalizacja systemów, sposoby i kompozycje do manipulacji sekwencją z domenami funkcjonalnymi
|
MX2015007743A
(es)
|
2012-12-17 |
2015-12-07 |
Harvard College |
Ingenieria del genoma humano guiada por ácido robonucleico.
|
CN104995302B
(zh)
|
2013-01-16 |
2021-08-31 |
爱默蕾大学 |
Cas9-核酸复合物及其相关用途
|
JP2016519652A
(ja)
|
2013-03-14 |
2016-07-07 |
カリブー・バイオサイエンシーズ・インコーポレイテッド |
核酸ターゲティング核酸の組成物および方法
|
WO2014204578A1
(en)
|
2013-06-21 |
2014-12-24 |
The General Hospital Corporation |
Using rna-guided foki nucleases (rfns) to increase specificity for rna-guided genome editing
|
US10760064B2
(en)
|
2013-03-15 |
2020-09-01 |
The General Hospital Corporation |
RNA-guided targeting of genetic and epigenomic regulatory proteins to specific genomic loci
|
WO2014144592A2
(en)
|
2013-03-15 |
2014-09-18 |
The General Hospital Corporation |
Using truncated guide rnas (tru-grnas) to increase specificity for rna-guided genome editing
|
US20140273230A1
(en)
|
2013-03-15 |
2014-09-18 |
Sigma-Aldrich Co., Llc |
Crispr-based genome modification and regulation
|
US11332719B2
(en)
|
2013-03-15 |
2022-05-17 |
The Broad Institute, Inc. |
Recombinant virus and preparations thereof
|
US9234213B2
(en)
|
2013-03-15 |
2016-01-12 |
System Biosciences, Llc |
Compositions and methods directed to CRISPR/Cas genomic engineering systems
|
CN105518146B
(zh)
|
2013-04-04 |
2022-07-15 |
哈佛学院校长同事会 |
利用CRISPR/Cas系统的基因组编辑的治疗性用途
|
WO2014186585A2
(en)
|
2013-05-15 |
2014-11-20 |
Sangamo Biosciences, Inc. |
Methods and compositions for treatment of a genetic condition
|
ES2670531T3
(es)
|
2013-05-29 |
2018-05-30 |
Cellectis S.A. |
Un método para producir una escisión de ADN precisa utilizando la actividad nickasa de Cas9
|
US9873907B2
(en)
|
2013-05-29 |
2018-01-23 |
Agilent Technologies, Inc. |
Method for fragmenting genomic DNA using CAS9
|
AU2014273085B2
(en)
|
2013-05-29 |
2020-10-22 |
Cellectis |
New compact scaffold of Cas9 in the type II CRISPR system
|
ES2883131T3
(es)
|
2013-05-29 |
2021-12-07 |
Cellectis |
Métodos para la modificación de células T para inmunoterapia utilizando el sistema de nucleasa CAS guiado por ARN
|
US9267135B2
(en)
|
2013-06-04 |
2016-02-23 |
President And Fellows Of Harvard College |
RNA-guided transcriptional regulation
|
KR102512979B1
(ko)
|
2013-06-04 |
2023-03-22 |
프레지던트 앤드 펠로우즈 오브 하바드 칼리지 |
Rna-가이드된 전사 조절
|
AU2014274840B2
(en)
|
2013-06-05 |
2020-03-12 |
Duke University |
RNA-guided gene editing and gene regulation
|
KR20160044457A
(ko)
|
2013-06-17 |
2016-04-25 |
더 브로드 인스티튜트, 인코퍼레이티드 |
서열 조작을 위한 탠덤 안내 시스템, 방법 및 조성물의 전달, 조작 및 최적화
|
CN105492611A
(zh)
|
2013-06-17 |
2016-04-13 |
布罗德研究所有限公司 |
用于序列操纵的优化的crispr-cas双切口酶系统、方法以及组合物
|
EP3620524A1
(en)
|
2013-06-17 |
2020-03-11 |
The Broad Institute, Inc. |
Delivery, engineering and optimization of systems, methods and compositions for targeting and modeling diseases and disorders of post mitotic cells
|
EP3597755A1
(en)
|
2013-06-17 |
2020-01-22 |
The Broad Institute, Inc. |
Delivery, use and therapeutic applications of the crispr-cas systems and compositions for targeting disorders and diseases using viral components
|
WO2014204727A1
(en)
|
2013-06-17 |
2014-12-24 |
The Broad Institute Inc. |
Functional genomics using crispr-cas systems, compositions methods, screens and applications thereof
|
US11459585B2
(en)
|
2013-07-09 |
2022-10-04 |
President And Fellows Of Harvard College |
Multiplex RNA-guided genome engineering
|
US10329587B2
(en)
|
2013-07-10 |
2019-06-25 |
President And Fellows Of Harvard College |
Orthogonal Cas9 proteins for RNA-guided gene regulation and editing
|
CN105392885B
(zh)
|
2013-07-19 |
2020-11-03 |
赖瑞克斯生物科技公司 |
用于产生双等位基因敲除的方法和组合物
|
US11306328B2
(en)
|
2013-07-26 |
2022-04-19 |
President And Fellows Of Harvard College |
Genome engineering
|
WO2015021426A1
(en)
|
2013-08-09 |
2015-02-12 |
Sage Labs, Inc. |
A crispr/cas system-based novel fusion protein and its application in genome editing
|
US9322037B2
(en)
|
2013-09-06 |
2016-04-26 |
President And Fellows Of Harvard College |
Cas9-FokI fusion proteins and uses thereof
|
US20160237455A1
(en)
|
2013-09-27 |
2016-08-18 |
Editas Medicine, Inc. |
Crispr-related methods and compositions
|
US9074199B1
(en)
|
2013-11-19 |
2015-07-07 |
President And Fellows Of Harvard College |
Mutant Cas9 proteins
|
WO2015089486A2
(en)
|
2013-12-12 |
2015-06-18 |
The Broad Institute Inc. |
Systems, methods and compositions for sequence manipulation with optimized functional crispr-cas systems
|
WO2015089427A1
(en)
|
2013-12-12 |
2015-06-18 |
The Broad Institute Inc. |
Crispr-cas systems and methods for altering expression of gene products, structural information and inducible modular cas enzymes
|
BR112016013547A2
(pt)
|
2013-12-12 |
2017-10-03 |
Broad Inst Inc |
Composições e métodos de uso de sistemas crispr-cas em distúrbios de repetições de nucleotídeos
|
WO2015086798A2
(en)
|
2013-12-13 |
2015-06-18 |
Cellectis |
New method of selection of algal-transformed cells using nuclease
|
US9963689B2
(en)
|
2013-12-31 |
2018-05-08 |
The Regents Of The University Of California |
Cas9 crystals and methods of use thereof
|
KR20230152175A
(ko)
|
2014-04-18 |
2023-11-02 |
에디타스 메디신, 인코포레이티드 |
암 면역요법을 위한 crispr-cas-관련 방법, 조성물 및 구성성분
|
WO2015188065A1
(en)
|
2014-06-05 |
2015-12-10 |
Sangamo Biosciences, Inc. |
Methods and compositions for nuclease design
|
US10077453B2
(en)
|
2014-07-30 |
2018-09-18 |
President And Fellows Of Harvard College |
CAS9 proteins including ligand-dependent inteins
|
EP3180426B1
(en)
|
2014-08-17 |
2019-12-25 |
The Broad Institute, Inc. |
Genome editing using cas9 nickases
|
CA2963820A1
(en)
|
2014-11-07 |
2016-05-12 |
Editas Medicine, Inc. |
Methods for improving crispr/cas-mediated genome-editing
|
KR20230070319A
(ko)
|
2014-11-21 |
2023-05-22 |
리제너론 파마슈티칼스 인코포레이티드 |
쌍 형성된 가이드 rna를 사용하는 표적화된 유전자 변형을 위한 방법 및 조성물
|
WO2016106236A1
(en)
|
2014-12-23 |
2016-06-30 |
The Broad Institute Inc. |
Rna-targeting system
|
EP3702456A1
(en)
|
2014-12-24 |
2020-09-02 |
The Broad Institute, Inc. |
Crispr having or associated with destabilization domains
|
US20180155708A1
(en)
|
2015-01-08 |
2018-06-07 |
President And Fellows Of Harvard College |
Split Cas9 Proteins
|
WO2016114972A1
(en)
|
2015-01-12 |
2016-07-21 |
The Regents Of The University Of California |
Heterodimeric cas9 and methods of use thereof
|
KR20170126875A
(ko)
|
2015-01-28 |
2017-11-20 |
파이어니어 하이 부렛드 인터내쇼날 인코포레이팃드 |
Crispr 하이브리드 dna/rna 폴리뉴클레오티드 및 사용 방법
|
EP3858990A1
(en)
|
2015-03-03 |
2021-08-04 |
The General Hospital Corporation |
Engineered crispr-cas9 nucleases with altered pam specificity
|
JP2018513681A
(ja)
|
2015-03-31 |
2018-05-31 |
エクセリゲン サイエンティフィック, インコーポレイテッドExeligen Scientific, Inc. |
細胞または生物のゲノムへのDNA配列の標的化組み込みのためのCas9レトロウイルスインテグラーゼおよびCas9レコンビナーゼ系
|
WO2016164797A1
(en)
|
2015-04-08 |
2016-10-13 |
University Of Pittsburgh - Of The Commonwealth System Of Higher Education |
Activatable crispr/cas9 for spatial and temporal control of genome editing
|
WO2016167300A1
(ja)
|
2015-04-13 |
2016-10-20 |
国立大学法人東京大学 |
光依存的に又は薬物存在下でヌクレアーゼ活性若しくはニッカーゼ活性を示す、又は標的遺伝子の発現を抑制若しくは活性化するポリペプチドのセット
|
GB201506509D0
(en)
|
2015-04-16 |
2015-06-03 |
Univ Wageningen |
Nuclease-mediated genome editing
|
CN106011104B
(zh)
|
2015-05-21 |
2019-09-27 |
清华大学 |
利用拆分Cas系统进行基因编辑和表达调控方法
|
US10392607B2
(en)
|
2015-06-03 |
2019-08-27 |
The Regents Of The University Of California |
Cas9 variants and methods of use thereof
|
WO2016205745A2
(en)
|
2015-06-18 |
2016-12-22 |
The Broad Institute Inc. |
Cell sorting
|
WO2016205759A1
(en)
|
2015-06-18 |
2016-12-22 |
The Broad Institute Inc. |
Engineering and optimization of systems, methods, enzymes and guide scaffolds of cas9 orthologs and variants for sequence manipulation
|
US10648020B2
(en)
|
2015-06-18 |
2020-05-12 |
The Broad Institute, Inc. |
CRISPR enzymes and systems
|
EP3436575A1
(en)
|
2015-06-18 |
2019-02-06 |
The Broad Institute Inc. |
Novel crispr enzymes and systems
|
US9790490B2
(en)
|
2015-06-18 |
2017-10-17 |
The Broad Institute Inc. |
CRISPR enzymes and systems
|
EP3929287A3
(en)
|
2015-06-18 |
2022-04-13 |
The Broad Institute, Inc. |
Crispr enzyme mutations reducing off-target effects
|
WO2017015015A1
(en)
|
2015-07-17 |
2017-01-26 |
Emory University |
Crispr-associated protein from francisella and uses related thereto
|
US10612011B2
(en)
|
2015-07-30 |
2020-04-07 |
President And Fellows Of Harvard College |
Evolution of TALENs
|
EP3341477B1
(en)
*
|
2015-08-28 |
2022-03-23 |
The General Hospital Corporation |
Engineered crispr-cas9 nucleases
|
US9926546B2
(en)
|
2015-08-28 |
2018-03-27 |
The General Hospital Corporation |
Engineered CRISPR-Cas9 nucleases
|
US9512446B1
(en)
|
2015-08-28 |
2016-12-06 |
The General Hospital Corporation |
Engineered CRISPR-Cas9 nucleases
|
EP3350203A4
(en)
|
2015-09-17 |
2019-06-26 |
The Regents of The University of California |
CAS9 VARIANTS POLYPEPTIDES COMPRISING INTERNAL INSERTIONS
|
JP2018532402A
(ja)
|
2015-09-24 |
2018-11-08 |
クリスパー セラピューティクス アーゲー |
Rnaプログラム可能エンドヌクレアーゼの新規のファミリーならびにゲノム編集および他の適用におけるそれらの使用
|
JP2018531261A
(ja)
|
2015-10-16 |
2018-10-25 |
テンプル ユニバーシティー オブ ザ コモンウェルス システム オブ ハイヤー エデュケーション |
Cpf1を用いた、rnaガイド遺伝子編集方法および組成物
|
KR20180133374A
(ko)
|
2015-10-22 |
2018-12-14 |
더 브로드 인스티튜트, 인코퍼레이티드 |
타입 vi-b crispr 효소 및 시스템
|
WO2017070633A2
(en)
*
|
2015-10-23 |
2017-04-27 |
President And Fellows Of Harvard College |
Evolved cas9 proteins for gene editing
|
US11566052B2
(en)
|
2015-11-11 |
2023-01-31 |
Lonza Ltd. |
CRISPR-associated (Cas) proteins with reduced immunogenicity
|
WO2017099494A1
(ko)
|
2015-12-08 |
2017-06-15 |
기초과학연구원 |
Cpf1을 포함하는 유전체 교정용 조성물 및 그 용도
|
US20190264186A1
(en)
|
2016-01-22 |
2019-08-29 |
The Broad Institute Inc. |
Crystal structure of crispr cpf1
|
US11530421B2
(en)
|
2016-02-01 |
2022-12-20 |
The Regents Of The University Of California |
Self-inactivating endonuclease-encoding nucleic acids and methods of using the same
|
US9896696B2
(en)
|
2016-02-15 |
2018-02-20 |
Benson Hill Biosystems, Inc. |
Compositions and methods for modifying genomes
|
US20200291370A1
(en)
|
2016-03-18 |
2020-09-17 |
President And Fellows Of Harvard College |
Mutant Cas Proteins
|
US20200172935A1
(en)
|
2016-04-16 |
2020-06-04 |
Ohio State Innovation Foundation |
Modified cpf1 mrna, modified guide rna, and uses thereof
|
CA3026055A1
(en)
|
2016-04-19 |
2017-10-26 |
The Broad Institute, Inc. |
Novel crispr enzymes and systems
|
CA3026110A1
(en)
|
2016-04-19 |
2017-11-02 |
The Broad Institute, Inc. |
Novel crispr enzymes and systems
|
US20190161743A1
(en)
|
2016-05-09 |
2019-05-30 |
President And Fellows Of Harvard College |
Self-Targeting Guide RNAs in CRISPR System
|
US20190345483A1
(en)
|
2016-05-12 |
2019-11-14 |
President And Fellows Of Harvard College |
AAV Split Cas9 Genome Editing and Transcriptional Regulation
|
US20190323038A1
(en)
|
2016-06-17 |
2019-10-24 |
Montana State Univesity |
Bidirectional targeting for genome editing
|
CA3028158A1
(en)
|
2016-06-17 |
2017-12-21 |
The Broad Institute, Inc. |
Type vi crispr orthologs and systems
|
US20190100745A1
(en)
|
2016-06-20 |
2019-04-04 |
Pioneer Hi-Bred International, Inc. |
Novel cas systems and methods of use
|
US10927383B2
(en)
|
2016-06-30 |
2021-02-23 |
Ethris Gmbh |
Cas9 mRNAs
|
AU2017302551B2
(en)
|
2016-07-26 |
2023-04-27 |
The General Hospital Corporation |
Variants of CRISPR from Prevotella and Francisella 1 (Cpf1)
|
US20210166783A1
(en)
|
2016-08-17 |
2021-06-03 |
The Broad Institute, Inc. |
Methods for identifying class 2 crispr-cas systems
|
WO2018035387A1
(en)
|
2016-08-17 |
2018-02-22 |
The Broad Institute, Inc. |
Novel crispr enzymes and systems
|
US11352647B2
(en)
|
2016-08-17 |
2022-06-07 |
The Broad Institute, Inc. |
Crispr enzymes and systems
|
JP2019531763A
(ja)
|
2016-09-07 |
2019-11-07 |
フラッグシップ パイオニアリング, インコーポレイテッド |
遺伝子発現をモジュレートするための方法および組成物
|
US20190241880A1
(en)
|
2016-09-13 |
2019-08-08 |
Jason Wright |
Proximity-dependent biotinylation and uses thereof
|
WO2018052247A1
(ko)
|
2016-09-13 |
2018-03-22 |
주식회사 툴젠 |
시토신 디아미나제에 의한 dna에서의 염기 교정 확인 방법
|
US11873504B2
(en)
|
2016-09-30 |
2024-01-16 |
The Regents Of The University Of California |
RNA-guided nucleic acid modifying enzymes and methods of use thereof
|
MX2019003678A
(es)
|
2016-09-30 |
2020-08-13 |
Univ California |
Enzimas modificadoras de ácido nucleico guiadas por arn y métodos de uso de estas.
|
US11242542B2
(en)
|
2016-10-07 |
2022-02-08 |
Integrated Dna Technologies, Inc. |
S. pyogenes Cas9 mutant genes and polypeptides encoded by same
|
KR102606680B1
(ko)
|
2016-10-07 |
2023-11-27 |
인티그레이티드 디엔에이 테크놀로지스 아이엔씨. |
S. 피오게네스 cas9 돌연변이 유전자 및 이에 의해 암호화되는 폴리펩티드
|
IT201600102542A1
(it)
|
2016-10-12 |
2018-04-12 |
Univ Degli Studi Di Trento |
Plasmide e sistema lentivirale contenente un circuito autolimitante della Cas9 che ne incrementa la sicurezza.
|
CA3039928A1
(en)
|
2016-10-14 |
2018-04-19 |
President And Fellows Of Harvard College |
Aav delivery of nucleobase editors
|
US20200172899A1
(en)
|
2016-10-14 |
2020-06-04 |
The General Hospital Corporation |
Epigenetically Regulated Site-Specific Nucleases
|
US11840694B2
(en)
|
2016-10-17 |
2023-12-12 |
Nanyang Technological University |
Truncated CRISPR-Cas proteins for DNA targeting
|
US11180778B2
(en)
|
2016-11-11 |
2021-11-23 |
The Regents Of The University Of California |
Variant RNA-guided polypeptides and methods of use
|
AU2017364084A1
(en)
|
2016-11-22 |
2019-05-16 |
Integrated Dna Technologies, Inc. |
CRISPR/Cpf1 systems and methods
|
US11674128B2
(en)
|
2016-12-12 |
2023-06-13 |
Tsinghua University |
Engineering of a minimal SaCas9 CRISPR/Cas system for gene editing and transcriptional regulation optimized by enhanced guide RNA
|
CA3046824A1
(en)
|
2016-12-14 |
2018-06-21 |
Wageningen Universiteit |
Thermostable cas9 nucleases
|
WO2018109101A1
(en)
|
2016-12-14 |
2018-06-21 |
Wageningen Universiteit |
Thermostable cas9 nucleases
|
US11377645B2
(en)
|
2016-12-16 |
2022-07-05 |
The Rockefeller University |
Compositions and methods using Cas9 with enhanced spacer acquisition function
|
US20200190699A1
(en)
|
2016-12-19 |
2020-06-18 |
Editas Medicine, Inc. |
Assessing nuclease cleavage
|
WO2018118968A1
(en)
|
2016-12-19 |
2018-06-28 |
Editas Medicine, Inc. |
Emulsion-based screening methods
|
JP7229923B2
(ja)
|
2017-01-06 |
2023-02-28 |
エディタス・メディシン、インコーポレイテッド |
ヌクレアーゼ切断を評価する方法
|
IT201700016321A1
(it)
*
|
2017-02-14 |
2018-08-14 |
Univ Degli Studi Di Trento |
Mutanti di cas9 ad alta specificita' e loro applicazioni.
|
US11111492B2
(en)
|
2017-03-06 |
2021-09-07 |
Florida State University Research Foundation, Inc. |
Genome engineering methods using a cytosine-specific Cas9
|
WO2018170015A1
(en)
|
2017-03-14 |
2018-09-20 |
The Regents Of The University Of California |
Engineering crispr cas9 immune stealth
|
AU2018240515A1
(en)
|
2017-03-24 |
2019-08-01 |
CureVac SE |
Nucleic acids encoding CRISPR-associated proteins and uses thereof
|
US20210047633A1
(en)
|
2017-03-29 |
2021-02-18 |
Editas Medicine, Inc. |
Selection methods
|
CN108690845B
(zh)
|
2017-04-10 |
2021-04-27 |
中国科学院动物研究所 |
基因组编辑系统和方法
|
US20180362590A1
(en)
|
2017-04-14 |
2018-12-20 |
Synthetic Genomics, Inc. |
Polypeptides with type v crispr activity and uses thereof
|
EP3612204A4
(en)
|
2017-04-21 |
2021-01-27 |
The General Hospital Corporation |
INDUCTIBLE, ADJUSTABLE AND MULTIPLEX HUMAN GENERATION CONTROL USING CRISPR-CPF1
|
CA3059956A1
(en)
|
2017-04-21 |
2018-10-25 |
The General Hospital Corporation |
Variants of cpf1 (cas12a) with altered pam specificity
|
US11530405B2
(en)
|
2017-04-24 |
2022-12-20 |
Dupont Nutrition Biosciences Aps |
Anti-CRISPR genes and proteins and methods of use
|
US11692184B2
(en)
|
2017-05-16 |
2023-07-04 |
The Regents Of The University Of California |
Thermostable RNA-guided endonucleases and methods of use thereof
|
EP3625338A4
(en)
|
2017-05-19 |
2021-01-20 |
Tsinghua University |
ENGINEERING OF A SACAS9 MINIMUM CRISPR / CAS SYSTEM FOR GENE EDITING AND TRANSCRIPTIONAL REGULATION OPTIMIZED BY AN IMPROVED GUIDE RNA
|
WO2018221685A1
(ja)
|
2017-05-31 |
2018-12-06 |
国立大学法人 東京大学 |
改変されたCas9タンパク質及びその用途
|
WO2018226855A1
(en)
|
2017-06-06 |
2018-12-13 |
The General Hospital Corporation |
Engineered crispr-cas9 nucleases
|
JP2020524497A
(ja)
|
2017-06-09 |
2020-08-20 |
エディタス・メディシン,インコーポレイテッド |
操作されたcas9ヌクレアーゼ
|
US10392616B2
(en)
|
2017-06-30 |
2019-08-27 |
Arbor Biotechnologies, Inc. |
CRISPR RNA targeting enzymes and systems and uses thereof
|
CA3069296A1
(en)
|
2017-07-07 |
2019-01-10 |
Toolgen Incorporated |
Target-specific crispr mutant
|
WO2019018041A1
(en)
|
2017-07-21 |
2019-01-24 |
Arizona Board Of Regents On Behalf Of Arizona State University |
MODULATION OF THE IMMUNE RESPONSE OF A HOST SPECIFIC TO HUMAN CAS9
|
KR20200036025A
(ko)
|
2017-08-15 |
2020-04-06 |
인텔리아 테라퓨틱스, 인크. |
메신저 리보핵산(mRNA)을 암호화하는 안정화된 핵산
|
WO2019040650A1
(en)
|
2017-08-23 |
2019-02-28 |
The General Hospital Corporation |
GENETICALLY MODIFIED CRISPR-CAS9 NUCLEASES HAVING MODIFIED PAM SPECIFICITY
|
EP3676378A4
(en)
|
2017-08-31 |
2021-06-09 |
The New York Genome Center |
PROCEDURES AND COMPOSITIONS USING CRIMP-CPF1 AND PAIRED GUIDE-CRISPR-RNA FOR PROGRAMMABLE GENOMIC DELETIONS
|
US11530396B2
(en)
|
2017-09-05 |
2022-12-20 |
The University Of Tokyo |
Modified CAS9 protein, and use thereof
|
US11713452B2
(en)
|
2017-09-08 |
2023-08-01 |
University Of North Texas Health Science Center |
Engineered CAS9 variants
|
WO2019060469A2
(en)
|
2017-09-19 |
2019-03-28 |
Massachusetts Institute Of Technology |
CAS9 STREPTOCOCCUS CANIS AS A GENOMIC ENGINEERING PLATFORM WITH NEW PAM SPECIFICITY
|
CA3111479A1
(en)
|
2017-09-26 |
2019-04-04 |
The Board Of Trustees Of The University Of Illinois |
Crispr/cas system and method for genome editing and modulating transcription
|
GB201716590D0
(en)
|
2017-10-10 |
2017-11-22 |
Univ Wageningen |
Thermostable cas9 nucleases with reduced off-target activity
|
WO2019083532A1
(en)
|
2017-10-26 |
2019-05-02 |
Excision Biotherapeutics Inc |
IDENTIFICATION OF GENE EDITION PROTEINS AND GENE EXCISION (TYPE CAS9 AND ARGONAUTE) FROM OTHER ORGANISMS
|
GB2582100B
(en)
|
2017-11-01 |
2023-05-17 |
Univ California |
CAS12C Compositions and methods of use
|
WO2019089804A1
(en)
|
2017-11-01 |
2019-05-09 |
The Regents Of The University Of California |
Casy compositions and methods of use
|
CA3080493A1
(en)
|
2017-11-01 |
2019-05-09 |
The Regents Of The University Of California |
Casz compositions and methods of use
|
WO2019089808A1
(en)
|
2017-11-01 |
2019-05-09 |
The Regents Of The University Of California |
Class 2 crispr/cas compositions and methods of use
|
EP3704237A1
(en)
|
2017-11-02 |
2020-09-09 |
Arbor Biotechnologies, Inc. |
Novel crispr-associated transposon systems and components
|
US20210363521A1
(en)
|
2017-11-09 |
2021-11-25 |
Vertex Pharmaceuticals Incorporated |
CRISPR/CAS Systems For Treatment of DMD
|
EP3707252A1
(en)
|
2017-11-10 |
2020-09-16 |
Novozymes A/S |
Temperature-sensitive cas9 protein
|
EP3710583A1
(en)
|
2017-11-16 |
2020-09-23 |
Astrazeneca AB |
Compositions and methods for improving the efficacy of cas9-based knock-in strategies
|
EP3728576A4
(en)
|
2017-12-22 |
2021-11-24 |
The Broad Institute, Inc. |
CAS12B SYSTEMS, METHODS AND COMPOSITIONS FOR SPECIFIC EDITING OF RNA BASES
|
EP3728588A4
(en)
|
2017-12-22 |
2022-03-09 |
The Broad Institute, Inc. |
CAS12A SYSTEMS, METHODS AND COMPOSITIONS FOR TARGETED RNA BASE EDITING
|
US20230193242A1
(en)
|
2017-12-22 |
2023-06-22 |
The Broad Institute, Inc. |
Cas12b systems, methods, and compositions for targeted dna base editing
|
WO2019126774A1
(en)
|
2017-12-22 |
2019-06-27 |
The Broad Institute, Inc. |
Novel crispr enzymes and systems
|
US20220307001A1
(en)
|
2018-02-27 |
2022-09-29 |
President And Fellows Of Harvard College |
Evolved cas9 variants and uses thereof
|
FI3765616T3
(fi)
|
2018-03-14 |
2023-08-29 |
Arbor Biotechnologies Inc |
Uusia CRISPR-DNA- ja RNA-kohdennusentsyymejä ja -järjestelmiä
|
PT3765615T
(pt)
|
2018-03-14 |
2023-08-28 |
Arbor Biotechnologies Inc |
Novas enzimas e sistemas de direcionamento de dna crispr
|
CN112424348A
(zh)
|
2018-03-19 |
2021-02-26 |
克里斯珀医疗股份公司 |
新颖的rna-可编程的内切核酸酶系统及其用途
|